 Erica Mandell
Concepts (140)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bronchopulmonary Dysplasia | 15 | 2025 | 378 | 4.720 |
Why?
| | Vitamin D | 7 | 2025 | 380 | 3.110 |
Why?
| | Vitamin D Deficiency | 3 | 2021 | 177 | 1.800 |
Why?
| | Hypertension, Pulmonary | 9 | 2025 | 1897 | 1.750 |
Why?
| | Lung | 12 | 2025 | 3940 | 1.730 |
Why?
| | Endotoxins | 6 | 2024 | 220 | 1.690 |
Why?
| | Infant, Premature | 8 | 2024 | 541 | 1.660 |
Why?
| | Persistent Fetal Circulation Syndrome | 2 | 2022 | 137 | 1.350 |
Why?
| | Pulmonary Alveoli | 3 | 2021 | 403 | 0.970 |
Why?
| | Animals, Newborn | 8 | 2025 | 834 | 0.930 |
Why?
| | Vascular Endothelial Growth Factor Receptor-1 | 1 | 2025 | 70 | 0.910 |
Why?
| | Rats | 11 | 2025 | 5487 | 0.830 |
Why?
| | Infant, Premature, Diseases | 2 | 2021 | 93 | 0.790 |
Why?
| | Vasodilator Agents | 2 | 2022 | 326 | 0.790 |
Why?
| | Anemia | 1 | 2023 | 162 | 0.760 |
Why?
| | Vascular Resistance | 2 | 2021 | 371 | 0.750 |
Why?
| | Thrombocytopenia | 1 | 2023 | 189 | 0.730 |
Why?
| | Nitric Oxide | 3 | 2022 | 896 | 0.730 |
Why?
| | Infant, Newborn | 14 | 2024 | 5772 | 0.710 |
Why?
| | Rats, Sprague-Dawley | 8 | 2025 | 2403 | 0.700 |
Why?
| | Cholestasis | 1 | 2023 | 232 | 0.690 |
Why?
| | Lung Compliance | 1 | 2020 | 48 | 0.680 |
Why?
| | Vitamins | 3 | 2019 | 173 | 0.670 |
Why?
| | Pregnancy | 12 | 2025 | 6423 | 0.660 |
Why?
| | Hyperoxia | 1 | 2020 | 90 | 0.640 |
Why?
| | Hernias, Diaphragmatic, Congenital | 2 | 2019 | 205 | 0.630 |
Why?
| | Respiratory Insufficiency | 1 | 2022 | 313 | 0.600 |
Why?
| | Ventilator-Induced Lung Injury | 1 | 2019 | 58 | 0.590 |
Why?
| | Angiogenesis Inducing Agents | 1 | 2018 | 24 | 0.580 |
Why?
| | Chorioamnionitis | 1 | 2018 | 40 | 0.570 |
Why?
| | Endothelial Cells | 3 | 2025 | 749 | 0.560 |
Why?
| | Lung Injury | 1 | 2020 | 211 | 0.560 |
Why?
| | Pulmonary Artery | 4 | 2015 | 1097 | 0.540 |
Why?
| | Autophagy | 1 | 2019 | 266 | 0.520 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2019 | 385 | 0.510 |
Why?
| | 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 2015 | 17 | 0.490 |
Why?
| | Receptors, Calcitriol | 1 | 2015 | 53 | 0.480 |
Why?
| | Fetal Development | 1 | 2018 | 287 | 0.470 |
Why?
| | Fetal Blood | 1 | 2017 | 318 | 0.460 |
Why?
| | Transcriptome | 1 | 2020 | 875 | 0.430 |
Why?
| | Placenta | 1 | 2018 | 716 | 0.370 |
Why?
| | Animals | 12 | 2025 | 35409 | 0.370 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2015 | 820 | 0.340 |
Why?
| | Heart Ventricles | 1 | 2015 | 781 | 0.340 |
Why?
| | Respiratory Physiological Phenomena | 2 | 2023 | 30 | 0.340 |
Why?
| | Sildenafil Citrate | 2 | 2021 | 59 | 0.330 |
Why?
| | Pulmonary Surfactants | 2 | 2021 | 106 | 0.310 |
Why?
| | Respiratory Tract Diseases | 2 | 2021 | 149 | 0.310 |
Why?
| | Administration, Inhalation | 2 | 2022 | 673 | 0.310 |
Why?
| | Infant | 9 | 2024 | 9018 | 0.290 |
Why?
| | Insulin-Like Growth Factor I | 2 | 2020 | 310 | 0.270 |
Why?
| | Female | 16 | 2025 | 68829 | 0.260 |
Why?
| | Humans | 19 | 2025 | 129847 | 0.240 |
Why?
| | Methacholine Chloride | 1 | 2024 | 52 | 0.220 |
Why?
| | X-Ray Microtomography | 1 | 2024 | 84 | 0.220 |
Why?
| | Propofol | 1 | 2024 | 63 | 0.210 |
Why?
| | Intestinal Atresia | 1 | 2023 | 14 | 0.200 |
Why?
| | Oxygen | 2 | 2021 | 916 | 0.200 |
Why?
| | Tracheostomy | 1 | 2024 | 129 | 0.190 |
Why?
| | Disease Models, Animal | 3 | 2025 | 4077 | 0.190 |
Why?
| | Sheep | 2 | 2015 | 845 | 0.190 |
Why?
| | Peptide PHI | 1 | 2020 | 2 | 0.180 |
Why?
| | Milrinone | 1 | 2021 | 29 | 0.180 |
Why?
| | Pregnancy, Animal | 1 | 2020 | 53 | 0.170 |
Why?
| | Hypoxia-Inducible Factor 1 | 1 | 2020 | 72 | 0.170 |
Why?
| | Epoprostenol | 1 | 2021 | 136 | 0.170 |
Why?
| | Prenatal Care | 2 | 2020 | 277 | 0.170 |
Why?
| | Angiogenic Proteins | 1 | 2020 | 16 | 0.170 |
Why?
| | Infant, Very Low Birth Weight | 1 | 2020 | 67 | 0.160 |
Why?
| | Postnatal Care | 1 | 2020 | 71 | 0.160 |
Why?
| | Precision Medicine | 1 | 2023 | 385 | 0.160 |
Why?
| | Infant, Extremely Premature | 1 | 2020 | 61 | 0.160 |
Why?
| | Sphingomyelin Phosphodiesterase | 1 | 2019 | 22 | 0.160 |
Why?
| | Phosphodiesterase 5 Inhibitors | 1 | 2019 | 37 | 0.150 |
Why?
| | Vitamin A | 1 | 2019 | 55 | 0.150 |
Why?
| | Respiration | 1 | 2019 | 193 | 0.150 |
Why?
| | Diuretics | 1 | 2019 | 76 | 0.150 |
Why?
| | Phosphodiesterase Inhibitors | 1 | 2019 | 89 | 0.150 |
Why?
| | Caffeine | 1 | 2019 | 62 | 0.150 |
Why?
| | Mesenchymal Stem Cell Transplantation | 1 | 2019 | 51 | 0.150 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2023 | 367 | 0.150 |
Why?
| | Progestins | 1 | 2019 | 78 | 0.150 |
Why?
| | Risk | 1 | 2021 | 860 | 0.150 |
Why?
| | Ceramides | 1 | 2019 | 112 | 0.150 |
Why?
| | Respiration, Artificial | 2 | 2019 | 617 | 0.140 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2019 | 145 | 0.140 |
Why?
| | Progesterone | 1 | 2019 | 245 | 0.140 |
Why?
| | Bronchodilator Agents | 1 | 2019 | 245 | 0.140 |
Why?
| | Survivors | 1 | 2019 | 464 | 0.130 |
Why?
| | Vitamin D3 24-Hydroxylase | 1 | 2015 | 15 | 0.120 |
Why?
| | Phenotype | 2 | 2023 | 3062 | 0.120 |
Why?
| | Calcifediol | 1 | 2015 | 31 | 0.120 |
Why?
| | Elastin | 1 | 2015 | 77 | 0.120 |
Why?
| | Adrenal Cortex Hormones | 1 | 2019 | 532 | 0.120 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2015 | 145 | 0.120 |
Why?
| | Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2014 | 53 | 0.110 |
Why?
| | Antibodies, Monoclonal, Murine-Derived | 1 | 2014 | 86 | 0.110 |
Why?
| | Arteriovenous Fistula | 1 | 2014 | 35 | 0.110 |
Why?
| | Hypoxia | 1 | 2021 | 1087 | 0.110 |
Why?
| | Pulmonary Veins | 1 | 2014 | 98 | 0.110 |
Why?
| | Amniotic Fluid | 1 | 2014 | 87 | 0.100 |
Why?
| | Risk Factors | 2 | 2024 | 9801 | 0.100 |
Why?
| | Fetus | 1 | 2017 | 782 | 0.100 |
Why?
| | Fetal Growth Retardation | 1 | 2018 | 549 | 0.100 |
Why?
| | Apoptosis | 1 | 2019 | 2489 | 0.080 |
Why?
| | Biomarkers | 2 | 2020 | 3971 | 0.080 |
Why?
| | Survival Rate | 1 | 2014 | 1872 | 0.080 |
Why?
| | Signal Transduction | 1 | 2020 | 4935 | 0.060 |
Why?
| | Gestational Age | 2 | 2020 | 876 | 0.060 |
Why?
| | Cells, Cultured | 1 | 2014 | 4102 | 0.060 |
Why?
| | Anesthetics, Intravenous | 1 | 2024 | 46 | 0.050 |
Why?
| | Treatment Outcome | 1 | 2018 | 10241 | 0.050 |
Why?
| | Infusions, Intravenous | 1 | 2024 | 402 | 0.050 |
Why?
| | Male | 6 | 2024 | 63759 | 0.050 |
Why?
| | Hypnotics and Sedatives | 1 | 2024 | 178 | 0.050 |
Why?
| | Analgesics | 1 | 2024 | 194 | 0.050 |
Why?
| | Pain, Postoperative | 1 | 2024 | 247 | 0.050 |
Why?
| | Amino Acids, Dicarboxylic | 1 | 2020 | 8 | 0.040 |
Why?
| | Injections, Intralesional | 1 | 2020 | 33 | 0.040 |
Why?
| | Tissue Culture Techniques | 1 | 2020 | 75 | 0.040 |
Why?
| | Pregnancy Outcome | 1 | 2023 | 392 | 0.040 |
Why?
| | Aftercare | 1 | 2021 | 206 | 0.040 |
Why?
| | Random Allocation | 1 | 2020 | 347 | 0.040 |
Why?
| | Reference Values | 1 | 2020 | 796 | 0.040 |
Why?
| | In Vitro Techniques | 1 | 2020 | 1092 | 0.040 |
Why?
| | Respiratory Function Tests | 1 | 2020 | 581 | 0.040 |
Why?
| | Pulmonary Circulation | 1 | 2020 | 431 | 0.040 |
Why?
| | Models, Animal | 1 | 2020 | 376 | 0.040 |
Why?
| | Blotting, Western | 1 | 2020 | 1204 | 0.040 |
Why?
| | Prospective Studies | 2 | 2020 | 7158 | 0.030 |
Why?
| | Vascular Diseases | 1 | 2020 | 240 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2020 | 1690 | 0.030 |
Why?
| | Incidence | 1 | 2023 | 2646 | 0.030 |
Why?
| | Chronic Disease | 1 | 2021 | 1724 | 0.030 |
Why?
| | Logistic Models | 1 | 2019 | 1989 | 0.030 |
Why?
| | Proteomics | 1 | 2020 | 1058 | 0.030 |
Why?
| | Child | 2 | 2023 | 20962 | 0.020 |
Why?
| | Child, Preschool | 1 | 2019 | 10522 | 0.010 |
Why?
| | Adolescent | 1 | 2021 | 20451 | 0.010 |
Why?
| | Adult | 1 | 2020 | 35634 | 0.010 |
Why?
|
|
Mandell's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|